author-photo

J Kobie

Merck & Co.

17

Papers

274

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase 3 trial in patients with gastroesophageal adenocarcinoma.

2021
Show All
- Source
- Cite
- Save
Citations (4)
1416P Genomic landscape of late-stage gastric cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (16)
1442P Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro + chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Evaluation of blood TMB (bTMB) in KEYNOTE-189: Pembrolizumab (pembro) plus chemotherapy (chemo) with pemetrexed and platinum versus placebo plus chemo as first-line therapy for metastatic nonsquamous NSCLC.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
843P Association of gene expression signatures and TMB with response to pembrolizumab (pembro) in patients (pts) with recurrent ovarian cancer (ROC) enrolled in KEYNOTE-100

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
OA04.06 Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (48)
LBA80Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) for metastatic NSCLC: Tissue TMB (tTMB) and outcomes in KEYNOTE-021, 189, and 407

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (44)
LBA36Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (7)